RISK OF DEATH FROM THE USE OF ATYPICAL ANTIPSYCHOTIC DRUGS FOR THE TREATMENT OF NEUROPYSCHIATRIC SYMPTOMS OF DEMENTIA: A NETWORK META-ANALYSIS

被引：0
|
作者：
Yunusa, I [1 ]
Eguale, T. [1 ]
Garba, A. E. [2 ]
Alsumali, A. [1 ]
机构：
[1] MCPHS Univ, Boston, MA USA
[2] St Louis Univ, St Louis, MO 63103 USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1375
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND2
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [21] Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
    Schneeweiss, Sebastian
    Setoguchi, Soko
    Brookhart, Alan
    Dormuth, Colin
    Wang, Philip S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (05) : 627 - 632
  • [22] Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis
    Zheng, Yong-Bo
    Shi, Le
    Zhu, Xi-Mei
    Bao, Yan-Ping
    Bai, Li-Juan
    Li, Jin-Qiao
    Liu, Jia-Jia
    Han, Ying
    Shi, Jie
    Lu, Lin
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 127 : 296 - 306
  • [23] The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis
    Zhang, Yangyu
    Liu, Yingyu
    Su, Yingying
    You, Yueyue
    Ma, Yue
    Yang, Guang
    Song, Yan
    Liu, Xinyu
    Wang, Mohan
    Zhang, Lili
    Kou, Changgui
    BMC PSYCHIATRY, 2017, 17
  • [24] The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis
    Yangyu Zhang
    Yingyu Liu
    Yingying Su
    Yueyue You
    Yue Ma
    Guang Yang
    Yan Song
    Xinyu Liu
    Mohan Wang
    Lili Zhang
    Changgui Kou
    BMC Psychiatry, 17
  • [25] Antipsychotic Drugs and Cognitive Function A Systematic Review and Pairwise Network Meta-Analysis
    Feber, Lena
    Peter, Natalie L.
    Chiocchia, Virginia
    Schneider-Thoma, Johannes
    Siafis, Spyridon
    Bighelli, Irene
    Hansen, Wulf-Peter
    Lin, Xiao
    Prates-Baldez, Daniel
    Salanti, Georgia
    Keefe, Richard S. E.
    Engel, Rolf R.
    Leucht, Stefan
    JAMA PSYCHIATRY, 2025, 82 (01) : 47 - 56
  • [26] Risk of venous thromboembolic events on antipsychotic drugs: a meta-analysis of observational studies
    Chapelle, C.
    Beyens, M. N.
    Quenet, S.
    Delavenne, X.
    Lacut, K.
    Mismetti, P.
    Laporte, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 75 - 76
  • [27] Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis
    Ceraso, Anna
    Lin, Jessie Jingxia
    Schneider-Thoma, Johannes
    Siafis, Spyridon
    Heres, Stephan
    Kissling, Werner
    Davis, John M.
    Leucht, Stefan
    SCHIZOPHRENIA BULLETIN, 2022, 48 (04) : 738 - 740
  • [28] Adverse events and treatment failure leading to discontinuation of recently approved antipsychotic drugs in schizophrenia: A network meta-analysis
    Tonin, Fernanda S.
    Piazza, Thais
    Wiens, Astrid
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    SCHIZOPHRENIA RESEARCH, 2015, 169 (1-3) : 483 - 485
  • [29] Review and meta-analysis of add-on tranylcypromine with antipsychotic drugs for the treatment of schizophrenia with predominant negative symptoms: a restoration of evidence
    Ulrich, Sven
    Messer, Thomas
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) : 1233 - 1248
  • [30] Atypical antipsychotic medications in the treatment of schizophrenia: A Bayesian meta-analysis of direct and indirect comparisons
    Mahmood, M. H.
    Malone, D. C.
    VALUE IN HEALTH, 2008, 11 (03) : A110 - A110
12345